Workflow
ASP Isotopes(ASPI)
icon
Search documents
ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC
Newsfilter· 2025-04-15 12:00
- Highly respected South African Businessman, Mr Sipho Maseko, former CEO of Telkom SA Soc Ltd and MD of Vodacom SA, Has Joined the Board of Directors of ASP Isotopes Inc. - Dr. Hendrik Strydom, PhD, Chief Technology Officer of ASP Isotopes Inc., is transitioning from the Board of Directors of ASP Isotopes Inc. to the Board of Managers of Quantum Leap Energy LLC. - The Company Intends to pursue the Separation of its Nuclear Fuels Business, Quantum Leap Energy LLC, and Specialist Isotope Products and Related ...
ASP Isotopes(ASPI) - 2024 Q4 - Earnings Call Transcript
2025-04-01 19:37
Nick Lawson Good morning, good afternoon, and good evening to wherever you are in the world. My name is Nick Lawson. I’m the CEO of OceanWall. I’m delighted to welcome you to the ASP Isotopes fiscal year 2024 results webinar. We’re delighted to have with us Paul Mann, Chairman and CEO, and Dr. . Hendrik Strydom, who’s ASPI’s Chief Technology Officer. Firstly, gentlemen, congratulations on this morning’s press release regarding Ytterbium-176, an incredible milestone for you. Before you tell us more about tha ...
ASP Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176
GlobeNewswire· 2025-04-01 12:17
- Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis' Pluvicto. - The Company expects to be able to achieve a 99.75% enrichment for Ytterbium-176 and offer highly enriched Ytterbium-176 for commercial sale during 2025. - The Company anticipates now being able to proceed with the plans to construct Nickel-64, Gadolinium-160 and Lithium-6/7 Quantum Enrichment facilities. - The Company intends to continue its discussions with nuclear regulat ...
ASP Isotopes(ASPI) - 2024 Q4 - Annual Report
2025-03-31 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41555 ASP Isotopes Inc. (Exact name of registrant as specified in its charter) Delaware 87-2618235 (State or other jurisdiction of incorporation or org ...
ASP Isotopes Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Webinar
Newsfilter· 2025-03-31 16:00
WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), announced that it will release its fourth quarter and fiscal year 2024 financial results after the close of financial markets today, March 31, 2025, with a webinar to follow tomorrow, Tuesday, April 1, 2025 at 10:00 am ET, 3:00 pm UK time, 4:00 pm South African time. Participating in the webinar will be Paul Mann, Chairman and CEO of the Company. Mr. Mann will give a review of the Company's finan ...
ASP Isotopes Inc. Commences Commercial Production of Enriched Silicon-28 at its Second Aerodynamic Separation Process (ASP) Enrichment Facility
Newsfilter· 2025-03-27 12:00
- Silicon-28 is an isotope that is believed to assist in enabling quantum computing and improving the performance of next generation semiconductors for artificial intelligence. - The Company expects to ship commercial product during 2Q25. - The Company has already entered into two purchase agreements with US-based customers for kilogram quantities of Silicon-28 and is in discussions with multiple other global customers for kilogram quantities. WASHINGTON, March 27, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. ...
ASP Isotopes Inc. Commences Commercial Production of Enriched Carbon-14 at its First Aerodynamic Separation Process (ASP) Enrichment Facility
GlobeNewswire· 2025-02-26 13:00
- The Company has commenced commercial production of enriched Carbon-14 at its first Aerodynamic Separation Process (ASP) enrichment facility. - The Company expects to ship commercial product around the middle of the year. - The Company previously entered into a multi-year, take-or-pay contract with a Canadian customer, valued at a minimum of approximately $2.4 million per annum. WASHINGTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced mate ...
ASP Isotopes Inc. to Present at Canaccord Genuity Sustainability Summit on Wednesday, February 26, 2025
GlobeNewswire· 2025-02-25 13:00
ASP Isotopes invites institutional investors to attend the upcoming virtual event by contacting their Canaccord Genuity representative Paul Mann, Chairman and Chief Executive Officer of ASP Isotopes, will participate in a panel discussion on the future of nuclear fission. The panel will also include representatives from TerraPower and Elementl Power WASHINGTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the d ...
Shareholders of ASP Isotopes Inc. Should Contact The Gross Law Firm Before February 3, 2025 to Discuss Your Rights – ASPI
GlobeNewswire News Room· 2025-02-03 16:21
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI). Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/asp-isotopes-inc-loss-submission-form/?id=126300&from=3 CLASS PERIOD: October 30 ...
DEADLINE NEXT WEEK: Berger Montague Advises ASP Isotopes (NASDAQ: ASPI) Investors to Contact the Firm Before February 3, 2025
GlobeNewswire News Room· 2025-01-31 20:33
PHILADELPHIA, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) on behalf of purchasers of ASP Isotopes securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Investors that suffered losses from ASP ISOTOPES (NASDAQ: ASPI) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn ...